2011
DOI: 10.1038/nchembio.632
|View full text |Cite
|
Sign up to set email alerts
|

The tRNA synthetase paralog PoxA modifies elongation factor-P with (R)-β-lysine

Abstract: The lysyl-tRNA synthetase paralog PoxA modifies elongation factor P (EF-P) with α-lysine at low efficiency. Cell-free extracts contained non-α-lysine substrates of PoxA that modified EF-P by a change in mass consistent with β–lysine, a substrate also predicted by genomic analyses. EF-P was efficiently, functionally, modified with (R)-β-lysine but not (S)-β-lysine or genetically encoded α-amino acids, indicating that PoxA has evolved an activity orthogonal to that of the canonical aminoacyl-tRNA synthetases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

5
104
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 88 publications
(110 citation statements)
references
References 24 publications
5
104
0
1
Order By: Relevance
“…Our data show that the absence of YfcM does not phenocopy loss of EF-P, PoxA, or YjeK. These results strongly suggest that YfcM is not a critical component of the modification pathway necessary for EF-P activity in vivo (8,9). Although not essential for EF-P activation, hydroxylation further stimulated puromycin reactivity, suggesting that it may function to modulate EF-P activity.…”
Section: Discussionmentioning
confidence: 65%
See 1 more Smart Citation
“…Our data show that the absence of YfcM does not phenocopy loss of EF-P, PoxA, or YjeK. These results strongly suggest that YfcM is not a critical component of the modification pathway necessary for EF-P activity in vivo (8,9). Although not essential for EF-P activation, hydroxylation further stimulated puromycin reactivity, suggesting that it may function to modulate EF-P activity.…”
Section: Discussionmentioning
confidence: 65%
“…EF-P is similar in size and shape to a tRNA and can be post-translationally modified by a lysyl-tRNA synthetase paralog, PoxA (7,8). In a reaction analogous to tRNA aminoacylation, PoxA activates (R)-␤-lysine and subsequently transfers it to a conserved residue (Lys-34) in EF-P (9). Attachment of a ␤-lysyl moiety is necessary for EF-P functionality both in vivo and in vitro (2,8).…”
mentioning
confidence: 99%
“…Our recent work determined that two enzymes, PoxA and YjeK, coordinately modify EF-P in a manner analogous to the modification of aIF5A and eIF5A with hypusine (42,48). Notably, the modification of EF-P occurs at a lysyl residue (lysine 34) that corresponds to the same position as the lysyl residue that is converted to hypusine in aIF5A and eIF5A.…”
mentioning
confidence: 99%
“…While PoxA bears close homology to the catalytic domain of the class II lysyl-tRNA synthetase (LysRS) family of enzymes that catalyze the addition of lysine to its cognate tRNA Lys , a number of studies have failed to show that PoxA can aminoacylate a tRNA (1,36,37). PoxA instead catalyzes the ligation of (R)-␤-lysine to the side chain of the conserved lysyl residue in EF-P to yield an unusual lysyl-␤-lysine moiety (42,48,60). Salmonella poxA and yjeK mutants display nearly identical phenotypes, including increased resistance to S-nitrosoglutathione (GSNO) and hypersusceptibility to a large number of unrelated antimicrobial compounds (7,42,55).…”
mentioning
confidence: 99%
“…(S)-α-lysine. [126] The crystal structure of the B. diazoefficiens homologue ( Figure 1C) showed that the structure of the homologue is remarkably similar to the atypical M. barkeri SerRS, although they share a weak sequence similarity (15 % identity). [122] The structure of B. diazoefficiens homologue recapitulates the structure of M. barkeri SerRS catalytic domain, with very few differences within and close to the active site.…”
Section: Amino Acid Activation By Serrs Homologuesmentioning
confidence: 94%